Switching From Preserved to Preserved-free Treatments for Glaucoma.

NCT01433900 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Tafluprost
DRUG: Latanoprost

Sponsor

Paolo Fogagnolo